Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Myriad Genetics Inc MYGN

Healthcare Biotechnology
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has... see more

Recent & Breaking News (NDAQ:MYGN)

EQUITY NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Cemex, S.A.B. de C.V.

Business Wire May 11, 2018

MYRIAD GENETICS, INC. INVESTOR UPDATE: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Utah on behalf of shareholders of Myriad Genetics, Inc

GlobeNewswire May 10, 2018

MYGN EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Myriad Genetics, Inc. and a Lead Plaintiff Deadline of June 19, 2018

Business Wire May 10, 2018

Important Deadline Notice for Myriad Genetics, Inc. Shareholders - MYGN

Accesswire May 10, 2018

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Myriad Genetics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2018

Business Wire May 9, 2018

53 Biggest Movers From Yesterday

Benzinga.com  May 9, 2018

Deadline Alert for Myriad Genetics, Inc. Shareholders in Class Action Lawsuit - MYGN

Accesswire May 8, 2018

The Klein Law Firm Announces a Class Action Commenced on Behalf of Myriad Genetics, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2018

Business Wire May 8, 2018

The Klein Law Firm Announces a Class Action Filed on Behalf of Myriad Genetics, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2018

GlobeNewswire May 8, 2018

Myriad Genetics Spikes On Better-Than-Expected Q3 Print

Benzinga.com  May 8, 2018

Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results

GlobeNewswire May 8, 2018

Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Myriad Genetics, Inc. Investors

GlobeNewswire May 7, 2018

Landmark Study Shows GeneSight® Test Led to Significant Improvement in Mental Health Outcomes for Patients with Major Depressive Disorder

GlobeNewswire May 7, 2018

MYGN INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Myriad Genetics, Inc. and a Lead Plaintiff Deadline of June 19, 2018

Business Wire May 6, 2018

Kaskela Law LLC: Shareholder Class Action Filed Against Myriad Genetics, Inc. - MYGN

GlobeNewswire May 6, 2018

MYRIAD GENETICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Myriad Genetics, Inc. - MYGN

GlobeNewswire May 4, 2018

MYGN SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Myriad Genetics, Inc. and a Lead Plaintiff Deadline of June 19, 2018

GlobeNewswire May 4, 2018

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Aceto Corporation (ACET) & Lead Plaintiff Deadline – June 25, 2018

GlobeNewswire May 4, 2018

Myriad Genetics to Present Five Studies at the Seventh International Symposium on Hereditary Breast and Ovarian Cancer

GlobeNewswire May 4, 2018

Myriad Lawsuit: Bernstein Liebhard LLP Reminds Investors of Important Deadline in Class Action Against Myriad Genetics, Inc. - MYGN

GlobeNewswire May 3, 2018
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested